Nicole L Davis1, William C Miller, Michael G Hudgens, Charles S Chasela, Dorothy Sichali, Dumbani Kayira, Julie A E Nelson, Susan A Fiscus, Gerald Tegha, Deborah D Kamwendo, Joseph Rigdon, Jeffrey S A Stringer, Jonathan J Juliano, Sascha R Ellington, Athena P Kourtis, Denise J Jamieson, Charles van der Horst. 1. *Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC; †Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC; ‡Currently, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA; §Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC; ‖Division of Epidemiology and Biostatistics, School of Public Health, University of Witwatersrand, Parktown, South Africa; ¶UNC Project, University of North Carolina, Lilongwe, Malawi; #Department of Microbiology and Immunology, School of Medicine, Center for AIDS Research, University of North Carolina, Chapel Hill, NC; **Division of Global Women's Health, Department of Obstetrics & Gynecology, Institute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, NC; and ††Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
BACKGROUND:Antiretroviral (ARV) interventions are used to reduce HIV viral replication and prevent mother-to-child transmission. Viral suppression relies on adherence to ARVs. METHODS: A 2-phase study was conducted using data from the Breastfeeding, Antiretrovirals, and Nutrition study. We included mothers randomized to 28 weeks of postpartum ARVs with ≥1 plasma or breastmilk specimen. All mothers who transmitted HIV to their infants from 2-28 weeks (n = 31) and 15% of mothers who did not (n = 232) were included. Adherence was measured by pill count [categorized as poor (0%-80%), partial (81%-98%), and near perfect (>98%)]. Associations between adherence and breastmilk RNA were assessed using mixed-effects models. Cox models were used to estimate associations between breastmilk RNA and HIV transmission. Using Monte Carlo simulation, we estimated the number of transmissions that would occur had everyone randomized to maternal ARVs been 90% and 100% adherent. RESULTS:Partial or near perfect ARV adherence significantly reduced the odds of having detectable (≥40 copies/mL) breastmilk RNA, compared with poor adherence (Odds Ratio (OR) 0.23, 95% CI: 0.08 to 0.67; OR 0.36, 95% CI: 0.16 to 0.81, respectively). Detectable breastmilk RNA was associated with increased breastmilk transmission compared with undetectable breastmilk RNA (hazard ratio 3.8, 95% CI: 1.2 to 12.1). All transmitting mothers had ≥1 plasma viral load specimen >100 copies per milliliter. An estimated similar number of transmissions would occur with 90% adherence compared with 100%. CONCLUSIONS: Helping patients adhere to ARVs throughout breastfeeding is important for realizing the full potential of recommended ARV interventions to prevent mother-to-child HIV transmission. Maintaining plasma viral load <100 copies per milliliter may prevent breastmilk transmission.
RCT Entities:
BACKGROUND: Antiretroviral (ARV) interventions are used to reduce HIV viral replication and prevent mother-to-child transmission. Viral suppression relies on adherence to ARVs. METHODS: A 2-phase study was conducted using data from the Breastfeeding, Antiretrovirals, and Nutrition study. We included mothers randomized to 28 weeks of postpartum ARVs with ≥1 plasma or breastmilk specimen. All mothers who transmitted HIV to their infants from 2-28 weeks (n = 31) and 15% of mothers who did not (n = 232) were included. Adherence was measured by pill count [categorized as poor (0%-80%), partial (81%-98%), and near perfect (>98%)]. Associations between adherence and breastmilk RNA were assessed using mixed-effects models. Cox models were used to estimate associations between breastmilk RNA and HIV transmission. Using Monte Carlo simulation, we estimated the number of transmissions that would occur had everyone randomized to maternal ARVs been 90% and 100% adherent. RESULTS: Partial or near perfect ARV adherence significantly reduced the odds of having detectable (≥40 copies/mL) breastmilk RNA, compared with poor adherence (Odds Ratio (OR) 0.23, 95% CI: 0.08 to 0.67; OR 0.36, 95% CI: 0.16 to 0.81, respectively). Detectable breastmilk RNA was associated with increased breastmilk transmission compared with undetectable breastmilk RNA (hazard ratio 3.8, 95% CI: 1.2 to 12.1). All transmitting mothers had ≥1 plasma viral load specimen >100 copies per milliliter. An estimated similar number of transmissions would occur with 90% adherence compared with 100%. CONCLUSIONS: Helping patients adhere to ARVs throughout breastfeeding is important for realizing the full potential of recommended ARV interventions to prevent mother-to-child HIV transmission. Maintaining plasma viral load <100 copies per milliliter may prevent breastmilk transmission.
Authors: L M Mofenson; J S Lambert; E R Stiehm; J Bethel; W A Meyer; J Whitehouse; J Moye; P Reichelderfer; D R Harris; M G Fowler; B J Mathieson; G J Nemo Journal: N Engl J Med Date: 1999-08-05 Impact factor: 91.245
Authors: Charles S Chasela; Michael G Hudgens; Denise J Jamieson; Dumbani Kayira; Mina C Hosseinipour; Athena P Kourtis; Francis Martinson; Gerald Tegha; Rodney J Knight; Yusuf I Ahmed; Deborah D Kamwendo; Irving F Hoffman; Sascha R Ellington; Zebrone Kacheche; Alice Soko; Jeffrey B Wiener; Susan A Fiscus; Peter Kazembe; Innocent A Mofolo; Maggie Chigwenembe; Dorothy S Sichali; Charles M van der Horst Journal: N Engl J Med Date: 2010-06-17 Impact factor: 91.245
Authors: Christine M Rousseau; Ruth W Nduati; Barbra A Richardson; Grace C John-Stewart; Dorothy A Mbori-Ngacha; Joan K Kreiss; Julie Overbaugh Journal: J Infect Dis Date: 2004-10-07 Impact factor: 5.226
Authors: Christine M Rousseau; Ruth W Nduati; Barbra A Richardson; Matthew S Steele; Grace C John-Stewart; Dorothy A Mbori-Ngacha; Joan K Kreiss; Julie Overbaugh Journal: J Infect Dis Date: 2003-02-18 Impact factor: 5.226
Authors: Jully A Okonji; Clement Zeh; Paul J Weidle; John Williamson; Benta Akoth; Rose O Masaba; Mary G Fowler; Timothy K Thomas Journal: J Acquir Immune Defic Syndr Date: 2012-10-01 Impact factor: 3.731
Authors: Nicole L Davis; William C Miller; Michael G Hudgens; Charles S Chasela; Dorothy Sichali; Dumbani Kayira; Julie A E Nelson; Jeffrey S A Stringer; Sascha R Ellington; Athena P Kourtis; Denise J Jamieson; Charles van der Horst Journal: AIDS Date: 2014-11-28 Impact factor: 4.177
Authors: Amanda H Corbett; Dumbani Kayira; Nicole R White; Nicole L Davis; Athena P Kourtis; Charles Chasela; Francis Martinson; Grace Phiri; Bonaface Musisi; Deborah Kamwendo; Michael G Hudgens; Mina C Hosseinipour; Julie Ae Nelson; Sascha R Ellington; Denise J Jamieson; Charles van der Horst; Angela Kashuba Journal: Antivir Ther Date: 2014-01-24
Authors: Arlene D Bardeguez; Jane C Lindsey; Maureen Shannon; Ruth E Tuomala; Susan E Cohn; Elizabeth Smith; Alice Stek; Shelly Buschur; Amanda Cotter; Linda Bettica; Jennifer S Read Journal: J Acquir Immune Defic Syndr Date: 2008-08-01 Impact factor: 3.731
Authors: Jennifer A Slyker; Michael H Chung; Dara A Lehman; James Kiarie; John Kinuthia; Sarah Holte; Kenneth Tapia; Francis Njiri; Julie Overbaugh; Grace John-Stewart Journal: PLoS One Date: 2012-01-11 Impact factor: 3.240
Authors: Nicole L Davis; Amanda Corbett; Josh Kaullen; Julie A E Nelson; Charles S Chasela; Dorothy Sichali; Michael G Hudgens; William C Miller; Denise J Jamieson; Athena P Kourtis Journal: J Acquir Immune Defic Syndr Date: 2019-04-01 Impact factor: 3.731
Authors: Pamela M Murnane; Peter Bacchetti; Judith S Currier; Sean Brummel; Hideaki Okochi; Nhi Phung; Alexander Louie; Karen Kuncze; Risa M Hoffman; Teacler Nematadzira; Dean K Soko; Maxensia Owor; Friday Saidi; Patricia M Flynn; Mary G Fowler; Monica Gandhi Journal: AIDS Date: 2019-08-01 Impact factor: 4.177
Authors: Landon Myer; Andrew D Redd; Elton Mukonda; Briana A Lynch; Tamsin K Phillips; Anna Eisenberg; Nei-Yuan Hsiao; Adam Capoferri; Alison Zerbe; William Clarke; Maia Lesosky; Autumn Breaud; James McIntyre; Daniel Bruno; Craig Martens; Elaine J Abrams; Steven J Reynolds Journal: Clin Infect Dis Date: 2020-01-16 Impact factor: 9.079
Authors: Lisa L Abuogi; Jose Castillo-Mancilla; Karen Hampanda; Kevin Owuor; Tobias Odwar; Maricianah Onono; Anna Helova; Janet M Turan; Peter L Anderson Journal: J Acquir Immune Defic Syndr Date: 2022-03-01 Impact factor: 3.771
Authors: Pamela M Murnane; James Ayieko; Eric Vittinghoff; Monica Gandhi; Chaplain Katumbi; Beteniko Milala; Catherine Nakaye; Peter Kanda; Dhayendre Moodley; Mandisa E Nyati; Amy J Loftis; Mary G Fowler; Pat Flynn; Judith S Currier; Craig R Cohen Journal: J Acquir Immune Defic Syndr Date: 2021-12-15 Impact factor: 3.771
Authors: Patricia M Flynn; Taha E Taha; Mae Cababasay; Kevin Butler; Mary G Fowler; Lynne M Mofenson; Maxensia Owor; Susan Fiscus; Lynda Stranix-Chibanda; Anna Coutsoudis; Devasena Gnanashanmugam; Nahida Chakhtoura; Katie McCarthy; Lisa Frenkel; Ingrid Beck; Cornelius Mukuzunga; Bonus Makanani; Dhayendre Moodley; Teacler Nematadzira; Bangani Kusakara; Sandesh Patil; Tichaona Vhembo; Raziya Bobat; Blandina T Mmbaga; Maysseb Masenya; Mandisa Nyati; Gerhard Theron; Helen Mulenga; David E Shapiro Journal: J Acquir Immune Defic Syndr Date: 2021-10-01 Impact factor: 3.771